cystic fibrosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Cystic fibrosis is caused by mutations in the CFTR gene, leading to defective or absent CFTR protein channels on epithelial cells. This results in improper chloride and water transport across cell membranes, causing thick, sticky mucus buildup in various organs.

• Secondary mechanism: The thick mucus obstructs airways in the lungs, leading to chronic respiratory infections and inflammation. Additionally, it blocks pancreatic ducts, impairing the release of digestive enzymes, resulting in malabsorption and nutritional deficiencies.

• Key complication: The persistent lung infections and inflammation can cause progressive lung damage, respiratory failure, and decreased life expectancy, highlighting the need for diligent respiratory management and nutritional support in affected patients.

Patient Profile

Demographics:

16-year-old female, high school student

History:

• Key past medical history: Diagnosed with cystic fibrosis at age 3, recurrent pulmonary infections, pancreatic insufficiency

• Current medications: Pulmozyme (dornase alfa), Creon (pancreatic enzymes), Azithromycin, Albuterol inhaler

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased cough and shortness of breath

• Key symptoms: Chronic productive cough, wheezing, fatigue, weight loss, frequent stools

• Vital signs: Temperature 100.4°F, Heart rate 110 bpm, Respiratory rate 24 breaths/min, Blood pressure 100/60 mmHg, Oxygen saturation 88% on room air

Section 1

As the healthcare team continues to assess the 16-year-old patient, initial findings indicate an exacerbation of her cystic fibrosis-related pulmonary issues. On auscultation, her lung fields reveal diffuse crackles and wheezing, particularly in the lower lobes, suggesting mucus plugging and possible atelectasis. Her productive cough has yielded thick, greenish sputum, indicative of a bacterial infection. Despite her efforts with airway clearance techniques and bronchodilator use, her oxygen saturation remains concerningly low at 88% on room air, prompting the initiation of supplemental oxygen. Her elevated temperature of 100.4°F, along with tachycardia and tachypnea, suggest an acute infectious process, likely a bacterial pneumonia secondary to her underlying condition.

Laboratory results further corroborate these findings, with a complete blood count revealing leukocytosis with a left shift, indicative of an active infection. Sputum cultures are pending, but the clinical picture suggests a possible Pseudomonas aeruginosa infection, a common and challenging pathogen in cystic fibrosis patients. Additionally, her recent weight loss and frequent stools raise concerns about exacerbated malabsorption, potentially due to inadequate pancreatic enzyme replacement therapy or increased metabolic demands from the infection.

The team adjusts her care plan to address these complications. Antibiotic therapy is initiated with a focus on broad-spectrum coverage until culture results are available, avoiding penicillin due to her allergy. Her pancreatic enzyme dosage is reviewed and adjusted to optimize nutrition. The patient is monitored closely for any changes in respiratory status, ensuring that interventions are timely and effective in preventing further deterioration. These measures are crucial as the team anticipates potential challenges in managing her complex needs, emphasizing the importance of a multidisciplinary approach in her ongoing care.

Section 2

As the healthcare team continues to monitor the patient, they observe a change in her respiratory status. Despite the initiation of supplemental oxygen and antibiotic therapy, her oxygen saturation remains at a precarious 90% even with 2 liters of supplemental oxygen. Her cough has become more frequent and forceful, yet her ability to expectorate sputum seems diminished, raising concerns about mucus clearance. A repeat chest X-ray reveals areas of increased opacity, consistent with worsening atelectasis and possible progression of the pneumonia.

Additionally, the patient's tachycardia has persisted, with her heart rate now consistently in the range of 120-130 beats per minute. Her respiratory rate remains elevated at 28 breaths per minute, and she continues to exhibit mild use of accessory muscles during inhalation. Laboratory results show a further increase in her white blood cell count to 18,000/mm³, with a neutrophil predominance, suggesting that the infection is still active. The team also notes slight hyponatremia, with her sodium level dropping to 132 mmol/L, possibly due to increased insensible losses and fluid shifts associated with the infection.

The healthcare team decides to escalate her care by increasing the intensity and frequency of her airway clearance techniques, introducing high-frequency chest wall oscillation therapy to enhance mucus mobilization. They also increase her supplemental oxygen to 3 liters per minute to maintain adequate oxygenation. Given her complex condition, a multidisciplinary team meeting is convened to reassess her current treatment regimen and ensure comprehensive management. They consider the potential need for intravenous hydration to address her electrolyte imbalance and plan for close monitoring of her nutritional status and overall response to these updated interventions.

Section 3

As the healthcare team implements the updated interventions, they closely monitor the patient's response to the intensified airway clearance techniques and increased supplemental oxygen. After several sessions of high-frequency chest wall oscillation therapy, there is a noticeable improvement in the patient's ability to mobilize and expectorate mucus. Her cough, while still frequent, becomes more productive, and she is able to clear some of the thick secretions that have been contributing to her respiratory distress. Encouragingly, her oxygen saturation shows a slight improvement, rising to 92% on 3 liters of oxygen, suggesting that the enhanced mucus clearance is aiding in ventilation and gas exchange.

However, during routine monitoring, the team observes a concerning development in her laboratory results. Her latest blood gases indicate a respiratory acidosis, with a pH of 7.30 and a PaCO2 of 50 mmHg, pointing to inadequate ventilation and potential CO2 retention. Additionally, her sodium level has continued to decline, now at 130 mmol/L, highlighting the need for careful management of her fluid and electrolyte balance. The healthcare team recognizes the importance of addressing these issues promptly to prevent further complications.

In response to these findings, the team decides to introduce non-invasive positive pressure ventilation (NPPV) to assist with her ventilation and reduce CO2 retention. They also initiate a tailored electrolyte replacement protocol to address her hyponatremia and maintain her fluid balance. As these interventions are put into place, the team remains vigilant, aware of the delicate balance required to manage her complex condition. They prepare for the possibility of further complications, understanding that continuous reassessment and adaptation of her treatment plan are essential to support her recovery and prevent deterioration.

Section 4

In the days following the introduction of non-invasive positive pressure ventilation (NPPV) and the electrolyte replacement protocol, the healthcare team observes several changes in the patient's condition. Initially, there is a slight improvement in her arterial blood gases, with the pH rising to 7.34 and PaCO2 decreasing to 45 mmHg, indicating a positive response to the ventilatory support. Her sodium levels have also begun to stabilize, now at 134 mmol/L, suggesting that the tailored electrolyte management is effectively addressing her hyponatremia. The patient reports feeling less breathless, and her work of breathing appears to have decreased, as evidenced by a reduction in accessory muscle use and an improvement in her respiratory rate, now consistently at 20 breaths per minute.

However, during a routine assessment, a new complication emerges. The patient begins to exhibit signs of gastrointestinal distress, including nausea and abdominal discomfort. She also reports a decrease in appetite and has had several loose stools over the past 24 hours. Concerned about the risk of malabsorption and its impact on her nutritional status, the team decides to conduct further diagnostic tests, including stool cultures and abdominal imaging, to determine the cause of these symptoms. They also initiate supportive measures, such as antiemetic medications and adjustments in her nutritional plan, to help manage her symptoms and maintain her caloric intake.

These developments prompt the healthcare team to consider the broader implications of her condition and treatment plan. They recognize the interconnected nature of her respiratory and gastrointestinal symptoms, understanding that the increased respiratory effort and ongoing mucus clearance may be influencing her gastrointestinal function. As they continue to monitor her closely, the team remains committed to a holistic approach, integrating respiratory, nutritional, and gastrointestinal management strategies to optimize her overall health and well-being. The focus shifts to refining her care plan and anticipating potential challenges, ensuring that she receives comprehensive support on her path to recovery.

Section 5

As the healthcare team delves deeper into the patient's gastrointestinal issues, the results of the stool cultures reveal the presence of Clostridium difficile, suggesting that the patient has developed a C. diff infection. This discovery is crucial, as it explains the recent onset of diarrhea and abdominal discomfort. The team quickly initiates an appropriate antibiotic regimen to target the infection, mindful of the balance needed to prevent further disruption of her gut flora. Additionally, they emphasize the importance of strict infection control measures to prevent the spread of this highly contagious bacterium within the healthcare facility.

In parallel, the abdominal imaging shows signs of mild bowel thickening, which could be indicative of an inflammatory process possibly exacerbated by the infection. The patient's nutritional plan is further refined, with a focus on easily digestible foods and continued electrolyte monitoring to counteract losses from diarrhea. Her fluid intake is carefully managed to prevent dehydration, and probiotics are considered to help restore gut balance once the acute phase of the infection is under control.

This new complication prompts the team to reassess the patient's overall care strategy, recognizing the interconnectedness of her cystic fibrosis, respiratory support, and gastrointestinal management. They reflect on the need for vigilant monitoring of potential side effects from medications and the importance of maintaining a robust hydration and nutritional status amidst these challenges. The patient's progress is closely tracked, with daily evaluations of her respiratory function, electrolyte balance, and gastrointestinal symptoms, ensuring that any further complications are swiftly addressed. As they navigate these complexities, the team remains committed to a holistic and dynamic approach, continuously adapting the care plan to support the patient's recovery and long-term health.